Streetbeat News

Stock Prices

NRG

NRG Energy shares are trading higher following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:04 pm

FWONA

Liberty Media shares are trading lower following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:03 pm

CVS

In the last three months, 5 analysts have published ratings on CVS Health (NYSE:CVS), with a mix of somewhat bullish and indifferent sentiments. The average 12-month price target has decreased by 7.8% to $65.0. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:01 pm

TNGX

Tango Therapeutics (NASDAQ:TNGX) has been analyzed by 7 analysts, showing a range of bullish to somewhat bullish sentiments. The average 12-month price target is $13.71, down 10.57% from the previous $15.33. Recent analyst actions include both raises and lowers in price targets, reflecting dynamic market conditions. Tango Therapeutics is a biotechnology company focused on precision oncology therapies.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:00 pm

CNQ

Canadian Natural Resources (NYSE:CNQ) has outperformed the market over the past 5 years, delivering an average annual return of 22.88%. A $1000 investment in CNQ 5 years ago would be worth $2,839.31 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:00 pm

SPY

USA Wholesale Inventories for June increased by 0.2%, matching both the estimate and the prior month's increase.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:00 pm

ISRG

Intuitive Surgical (NASDAQ:ISRG) has significantly outperformed the market over the past 10 years, delivering an average annual return of 24.53%. A $1000 investment in ISRG 10 years ago would be worth $9,045.45 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:00 pm

NVS

The FDA has granted accelerated approval to Novartis AG's (NYSE:NVS) Fabhalta for the treatment of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). This approval is based on interim results from the Phase 3 APPLAUSE-IgAN study, showing a significant reduction in proteinuria. Continued approval will depend on further clinical benefit verification. Novartis is also developing two additional IgAN therapies.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 1:52 pm

DIS

FSLY

INTC

MODG

TXT

Top Wall Street analysts downgraded several major stocks, including The Walt Disney Company (DIS), Textron Inc. (TXT), Fastly, Inc. (FSLY), Intel Corporation (INTC), and Topgolf Callaway Brands Corp. (MODG). These downgrades led to notable declines in their share prices.

Portfolio Pulse from Avi Kapoor

August 08, 2024 | 1:51 pm

FOUR

Shift4 Payments (NYSE:FOUR) reported a 30% year-on-year revenue increase for Q2 2024, reaching $827 million, though it missed the analyst consensus of $857.23 million. The company's adjusted EPS of 96 cents beat the consensus estimate of 86 cents. Payments-based revenue and subscription revenue saw significant growth, and the stock gained 7.62% following the earnings report.

Portfolio Pulse from Anusuya Lahiri

August 08, 2024 | 1:50 pm